News/Applied Biologics Announces Successful Manufactu…
GlobeNewswireUnresolved

Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program

Applied Biologics announces manufacture of its first research construct for the preclinical DMOAD Gene Therapy Program.

Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program